Treatment of PAF With the Synaptic System
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 128 participants.
Also called NCT05905835
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 128 participants
- Sponsor
- Synaptic Medical Corporation
- Registry
-
NCT05905835
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05905835. Allocation not applicable; no masking; primary purpose treatment. Start 2023-09-20 (actual); primary completion 2025-11-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Treatment of PAF With the Synaptic System
- Acronym
- Sensation
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- Synaptic Cryoablation System
- Lead sponsor
- Synaptic Medical Corporation
Record details
- Record id
cardio:ct-nct05905835- Content hash
ecedc5fb7b15af7311d160edd0102c865769f16b714e05c14f71264c271c4bbe